Patent · US Active

Tubulysin analogs and methods for their preparation

US10723727B2 · kind B2 · utility

0Cited by
8References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 2017
Grant dateJul 28, 2020
Priority date
Expiry dateJan 27, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to novel cytotoxic tubulysin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.